Vigonvita Life Sciences Co., Ltd. has scheduled an Extraordinary General Meeting (EGM) for 10:00 a.m. on Thursday, 23 April 2026, at 8/F, Building A, No. 108 Yuxin Road, Suzhou Industrial Park, Suzhou, PRC.
The sole agenda item, tabled as a special resolution, seeks shareholder approval for amendments to the company’s Articles of Association.
Shareholders of H Shares must be on the register as at 23 April 2026 to exercise voting rights. The register will be closed from Monday, 20 April 2026 through Thursday, 23 April 2026 (both days inclusive). To qualify, completed transfer documents and relevant share certificates must be lodged with Computershare Hong Kong Investor Services Limited by 4:30 p.m. on Friday, 17 April 2026.
All resolutions will be decided by poll pursuant to Hong Kong Listing Rules. Poll results will be disclosed on the HKEX news website and the company’s website after the meeting.
Shareholders may appoint one or more proxies; completed proxy forms must reach Computershare Hong Kong Investor Services Limited no later than 10:00 a.m. on Wednesday, 22 April 2026 (Hong Kong time). Personal identification will be required for attendance.
The notice, dated 8 April 2026, is issued by Chairman, Executive Director, Chief Executive Officer and General Manager Dr. Tian Guanghui. The board currently comprises two executive directors (Dr. Tian Guanghui, Dr. Hu Tianwen), one non-executive director (Mr. Liu Haoxuan) and three independent non-executive directors (Dr. Ju Dianwen, Ms. Cao Xinwen, Dr. Xu Hongxi).
Comments